Trade Summary

3 days ago, TETRAULT LYNN A., serving as Dir at NEOGENOMICS INC (NEO), sold 5,307 shares at $11.10 per share, for a total transaction value of $58,907.70. Following this transaction, TETRAULT LYNN A. now holds 86,115 shares of NEO.

This sale represents a 5.80% decrease in TETRAULT LYNN A.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 4:07 PM ET, 2 days after the trade was made.

NEOGENOMICS INC operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.